Home » Newsletters » BioWorld Science

BioWorld Science

May 12, 2005

View Archived Issues

A new drug delivery system for the selective targeting of paclitaxel

Sodium pyruvate provides neuroprotection following severe hypoglycemic shock

Xanthohumol represents a new cancer therapy for hypoxic tumors

Preclinical and clinical data presented on AG-013958

Data presented on VEGF Trap: a potential treatment for neovascular eye disease

Medivir offers first quarter interim report

Cambridge Biostability signs agreement for Acambis' HolaVax-ETEC vaccine

Elevated levels of immunomodulatory IDO mediate adalimumab psoriasis therapy

FDA extends review date of dalbavancin NDA

Genta and Aventis terminate Genasense agreement

Crompton and Great Lakes Chemical to form Chemtura

CYT009-GhrQb enters phase I/II trial for obesity

CP-31398 suppresses UVB-induced squamous cell carcinoma in hairless mice via activation of p53

Topical NF-kappaB Decoy: safe and effective in animal models of atopic dermatitis

Sebocytes: novel target cells for active vitamin D analogues

Novel antidiabetic agents imparted in recent patents

Phase II data support the use of APD-356 in the management of obesity

Ono and Medarex to develop anti-PD-1 antibody for cancer

Patents describe therapeutic agents for gastrointestinal and liver disorders

SCRAS reports use of botulinum toxin for respiratory distress

Prasterone significantly increases bone mineral density in female lupus patients

Ixabepilone administered daily for three consecutive days well tolerated in phase I study

Encouraging results for pirfenidone in idiopathic pulmonary fibrosis

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 13, 2026.
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 10, 2026
MSD synthesizes α-synuclein PET agents
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has prepared and tested new positron emission tomography (PET) agents for binding and imaging α-synuclein (SNCA) for the diagnosis...
Muscarinic M4 receptor positive allosteric modulators described in Neurosterix patent
BioWorld Science
Neurosterix Pharma Sarl has divulged 3-cyclopropylpyrazole derivatives acting as muscarinic M4 receptor positive allosteric modulators. They are reported to be...